Provide guideline directed medical tx for HF In all pts perform basic clinical eval address modifiable risk factors obesity physical inactivity EtOH consumption smoking DM HTN and assess stroke risk to determine need for anticoagulation CHA2DS2 VASc If ne

By rray, 26 January, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. <i>Eur Heart J.</i> 2021 Feb 1;42(5):373-498. <a href=https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehaa612/33799442/ehaa612.pdf><u>Free, full-text PDF</u></a>
Detail Type
Text
Patient Type Detail Header (Long)
Provide guideline-directed medical tx for HF. In all pts, perform basic clinical eval, address modifiable risk factors (obesity, physical inactivity, EtOH consumption, smoking, DM, HTN), and assess stroke risk to determine need for anticoagulation (<a href=https://online.epocrates.com/contextuallink/medCalc/AtrialFibCHADSVASc.htm?activeMedCalcName=CHADS-VASc+Score+for+Stroke+Risk+in+Arial+Fibrillation+%28CHA%5B2%5DS%5B2%5D-VASc%29><u>CHA<sub>2</sub>DS<sub>2</sub>-VASc</u></a>). If new dx of HFrEF and AF, suspect arrhythmia-induced cardiomyopathy and take early and aggressive approach to rhythm control. Ablation for rhythm control 1st-line tx in many.